Ezhova et al.
-17.05 (ddt, 1H, Rh-H, JHH ) 11.6, JPH ) 14.0, JRhH ) 17.6),
1.39 (s, 3H, CH3), 1.49 (s, 3H, CH3), 2.81 (br s, 2H, NH2), 7.43-
7.52 (m, 14H, arom + NH), 7.60-7.72 (m, 17H, arom). MS: 744
([M - PF6]+, 5%), 627 ([Rh(PPh3)2]+, 100%). IR: 2066 (νRh-H),
1671 (νCdO), 1543 (νCdN). Anal. Calcd for C40H41N3OF6P3Rh
(5)‚0.5CH2Cl2: C, 52.20; H, 4.55: N, 4.51. Found: C, 52.17; H,
4.62; N, 4.36.
cis,trans-[Rh(H)2(PPh3)2{Et(Me)CdN-NHC(O)NH2}]PF6 (6).
Compound 1a (18.4 mg, 0.021 mmol) and butanone-semicarba-
zone (2.7 mg, 0.021 mmol) were used. Yield 13.1 mg (70%).
31P{1H} NMR: δ 43.42 (d, JRhP ) 118), -143.2 (septet, PF6-).
1H NMR: δ -20.28 (ddt, 1H, Rh-H, JHH ) 11.3, JPH ) 15.0;
JRhH ) 21.0), -16.50 (ddt, 1H, Rh-H, JHH ) 11.4; JPH ) 15.0;
JRhH ) 17.3), 0.34 (t, 3H, CH3CH2, JHH ) 7.5), 1.49 (s, 3H,
CH3Cd), 2.13 (m, 2H, CH3CH2), 2.85 (br s, 2H, NH2), 7.4-7.55
(m, 19H, arom + NH), 7.55-7.7 (m, 12H, arom). MS: 758
([M - PF6]+, 18%), 627 ([Rh(PPh3)2]+, 65%), 307 (31%), 285
(16%), 154 (100%), 136 (64%). IR: 2047 (νRh-H), 1667 (νCdO),
1544 (νCdN). Anal. Calcd for C41H43N3OF6P3Rh (6)‚Me2CO: C,
54.95; H, 5.14; N, 4.37. Found: C, 54.87; H, 5.05; N, 4.52.
After ∼20 days in acetone, 6 is partially (∼40%) converted to
6a. 31P{1H} NMR: δ 43.57 (d, JRhP ) 118), -143.2 (septet, PF6-).
1H NMR: δ -20.48 (ddt seen as m, 1H, Rh-H), -16.55 (ddt seen
as m, 1H, Rh-H, overlapping with hydride of 6), 0.66 (t, 3H,
JRhH ) 19.5), 1.91 (s, 3H, CH3C), 2.83 (br s, 2H, NH2), 3.84 (s,
18H, OCH3), 6.95-7.05 (m, 12H, arom), 7.15 (pseudo-t, JHH
)
7.74, 2H, dCPhm-H), 7.25-7.55 (m, 16H, arom + NH). MS: 986.2
([M - PF6]+, 100%). A satisfactory elemental analysis could not
be obtained.
cis,trans-[Rh(H)2(P(C6H4-p-F)3)2{(Ph(Me)CdNsNHC(O)-
NH2}]PF6 (3e). Compound 1e (19.7 mg, 0.020 mmol) and the
semicarbazone (3.52 mg, 0.020 mmol) were used. Yield 15.5 mg
(73.5%). 31P{1H} NMR: δ 39.30 (d, JRhP ) 119), -143.2 (septet,
PF6-). H NMR: δ -20.36 (ddt, 1H, Rh-H, JHH ) 11.5, JPH
)
1
13.7, JRhH ) 19.4), -17.03 (ddt, 1H, Rh-H, JHH )11.5, JPH )16.1,
JRhH ) 18.9), 2.10 (s, 3H, CH3), 2.91 (br s, 2H, NH2), 6.92 (d, 2H,
JHH ) 8.0, dCPho-H), 7.17 (pseudo-t, 2H, JHH ) 8.0, dCPhm-H),
7.25-7.65 (m, 26H, arom + NH). MS: 912 ([M - PF6]+, 9%),
735 ([Rh(P(C6H4-p-F)3)2]+, 100%), 596 (25%), 323 (60%). IR:
2062 (νRh-H), 1669 (νCdO), 1588 (νCdN). Anal. Calcd for C45H36N3-
OF12P3Rh: C, 51.01; H, 3.52; N, 3.97. Found: C, 50.70; H, 3.60;
N, 4.08.
cis,trans-[Rh(H)2(PPh2Et)2{Ph(Me)CdNsNHC(O)NH2}]-
PF6 (3f). Compound 1f (20.0 mg, 0.025 mmol) and the semicar-
bazone (4.50 mg, 0.025 mmol) were used in this in situ synthesis.
31P{1H} NMR: δ 38.14 (d, JRhP ) 116), -143.2 (septet, PF6-).
1H NMR: δ -21.33 (ddt, 1H, Rh-H, JHH ) 11.9, JPH ) 15.2,
JRhH ) 20.9), -17.81 (ddt, 1H, Rh-H, JHH ) 11.9, JPH ) 15.5,
JRhH ) 20.0), 0.97 (pseudo-pentet, 6H, CH3CH2P, JHH ) 7.5,
JPH ) 9.1), 1.77 (s, 3H, CH3C)), 2.11 (m, 2H, CH3CH2P), 2.41
(m, 2H, CH3CH2P), 3.48 (br s, 2H, NH2), 7.04 (d, 2H, JHH ) 6.8,
dCPho-H), 7.25 (pseudo-t, 2H, JHH ) 6.9, dCPhm-H), 7.34-7.66
(m, 22H, arom + NH).
JHH ) 7.6, CH3CH2), 1.54 (s, 3H, CH3Cd), 1.71 (q, 2H, JHH
7.6, CH3CH2).
)
From the c,t,c-[Rh(H)2(PR3)2(acetone)2]+ precursors (2b-2g),
prepared analogously in situ in acetone, the dihydrido-acetophe-
none semicarbazone complexes were isolated (3b-e) or formed in
situ (3f, 3g). Reaction of 2h with acetophenone semicarbazone gave
the isolated hydrido-orthometalated complex 8.
cis,trans-[Rh(H)2(PPh2Me)2{PhC(Me)dNsNHC(O)NH2}]-
PF6 (3g). Compound 1g (10.0 mg, 0.013 mmol) and PhC-
(Me)dNsN(H)CONH2 (2.35 mg, 0.013 mmol) were placed in an
NMR tube equipped with a J-Young valve, and then ∼0.6 mL of
dry, degassed acetone-d6 was condensed into this tube. The resulting
solution was exposed to 1 atm of H2 at room temperature, and after
2 h ∼45% of 1g had reacted to form 3g: 31P{1H} NMR: δ 21.44
cis,trans-[Rh(H)2(PPh2C6H4-p-Me)2{Ph(Me)CdNsNHC(O)-
NH2}]PF6 (3b). Compound 1b (15.3 mg, 0.017 mmol) and
acetophenone-semicarbazone (3.00 mg, 0.017 mmol) were used
here. Yield 11.6 mg (70.5%). 31P{1H} NMR: δ 41.08 (d, JRh-P
)
120), -143.2 (septet, PF6-). H NMR: δ -20.5 (ddt, 1H, Rh-H,
JHH ) 11.7; JPH ) 13.2; JRhH ) 19.7), -17.05 (ddt, 1H, Rh-H,
JHH ) 11.7, JPH ) 15.6, JRhH ) 19.1), 1.90 (s, 3H, CH3Cd), 2.38
(s, 6H, p-CH3), 2.85 (br s, 2H, NH2), 6.88 (d, 2H, JHH ) 7.5,
dCPho-H), 7.09 (pseudo-t, 2H, JHH ) 8.0, dCPhm-H), 7.25-7.6
(m, 30H, arom + NH). MS: 931 (70%), 832 ([M - PF6 - 2H]+,
7.5%), 655 ([Rh(PPh2C6H4-p-Me)2]+, 100%). IR: 2064 (νRh-H),
1670 (νCdO), 1538 (νCdN). Anal. Calcd for C51H55N3OF6P3Rh: C,
57.62; H, 4.84; N, 4.29. Found: C, 57.40; H, 4.84; N, 4.50.
cis,trans-[Rh(H)2(P(C6H4-p-Me)3)2{Ph(Me)CdNsNHC(O)-
NH2}]PF6 (3c). Compound 1c (21.2 mg, 0.022 mmol) and the
semicarbazone (3.89 mg, 0.022 mmol) were used. Yield 16 mg
1
(d, JRhP ) 114), -143.2 (septet, PF6-). H NMR: δ -20.99 (ddt,
1
1H, Rh-H, JHH ) 11.9, JPH ) 17.3, JRhH ) 21.5), -17.81 (ddt, 1H,
Rh-H, JHH ) 11.9, JPH ) 16.1, JRhH ) 21.5), 1.91 (s, 3H, CH3C),
1.48 (br s, 6H, P-CH3), 7.1-7.5 (m, 26H, arom + NH).
After 2 days, 1g was no longer present, but most of 3g had
“decomposed” to a species with δP 33.82 (dd, JRhP ) 180, JPP
)
64) and 37.11 (dd, JRhP ) 193, JPP ) 64), considered to be [Rh-
1
(PPh2Me)2{PhC(Me)dNsN(H)CONH2}]PF6 (7). No hydride H
NMR signals were seen. An MS of this solution showed peaks at
680 ([M - PF6]+, 3%), 503 ([Rh(PPh2Me)2]+, 7%), and 154
(100%).
(70.2%). 31P{1H} NMR: δ 39.85 (d, JRhP ) 119), -143.2 (septet,
[Rh(H)(PPhMe2)2{o-C6H4C(Me)dNsNHC(O)NH2}]PF6 (8).
The procedure to generate 8 was identical to the one used for the
preparation of 3a, but with the reactants 1h (36.1 mg, 0.057 mmol)
and PhC(Me)dNNHC(O)NH2 (10.1 mg, 0.057 mmol). The product
solution was then treated with Et2O (∼1 mL), when an oily layer
became evident. The acetone/ether solution was decanted from the
oil and pumped to dryness. The residue was redissolved in a C6H6
(15 mL)/CH2Cl2 (2 mL) mixture, and the solution concentrated to
precipitate a light yellow solid. Yield 11.5 mg (28.7%). 31P{1H}
NMR (in situ): δ 20.94 (dd, JRhP ) 129.9, JPP ) 32), 21.10 (dd,
1
PF6-). H NMR: δ -20.59 (ddt, 1H, Rh-H, JHH ) 12.6, JPH
)
)
15.9, JRhH ) 19.7), -17.13 (ddt, 1H, Rh-H, JHH ) 12.6, JPH
16.0; JRhH ) 19.1), 1.48 (s, 3H, CH3Cd), 2.31 (s, 6H, p-CH3),
2.40 (s, 12H, p-CH3), 6.92 (d, 2H, JHH ) 7.5, dCPho-H), 7.12
(pseudo-t, 2H, JHH ) 7.7, dCPhm-H), 7.2-7.7 (m, 26H, arom +
NH). MS: 888 ([M - 2H - PF6]+, 10%), 711 ([Rh(P(C6H4-p-
Me)3)2]+, 100%). IR: 2092 (νRh-H), 1661 (νCdO), 1600 (νCdN). Anal.
Calcd for C51H55N3OF6P3Rh (3c)‚1.5H2O: C, 57.63; H, 5.50; N,
3.95. Found: C, 57.50; H, 5.25; N, 3.83.
JRhP ) 122, JPP ) 32), -143.2 (septet, PF6-). H NMR (in situ):
1
cis,trans-[Rh(H)2(P(C6H4-p-OMe)3)2{Ph(Me)CdNsNHC(O)-
NH2}]PF6 (3d). Compound 1d (18.7 mg, 0.018 mmol) and the
semicarbazone (3.13 mg, 0.018 mmol) were used. Yield 12.3 mg
δ -18.7 (ddd, 1H, Jtrans-PH ) 20.1, Jcis-PH ) 15.7, JRhH ) 32.2,
Rh-H), 1.16 (d, 3H, JPH ) 10.7, PCH3), 1.43 (d, 3H, JPH ) 10.7,
PCH3), 1.69 (d, 3H, JPH ) 11.7, PCH3), 1.81 (d, 3H, JPH ) 11.7,
PCH3), 2.60 (s, 3H, CH3C). MS: 655 (10%), 592 ([M - Me -
F6]+, 6%), 556 ([M - PF6]+, 15%), 379 ([Rh(PPhMe2)2]+ 100%).
(61.8%). 31P{1H} NMR: δ 37.57 (d, JRhP ) 119), -143.2 (septet,
PF6-). H NMR: δ -20.63 (ddt, 1H, Rh-H, JHH ) 10.5, JPH
)
1
16.1, JRhH ) 19.7), -17.2 (ddt, 1H, Rh-H, JHH ) 10.5, JPH ) 16.4,
1484 Inorganic Chemistry, Vol. 44, No. 5, 2005